Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Wegovy (semaglutide) Injector 1.7 mg/0.75 mL, 4 Pens Per Box is a medication used for chronic weight management in adults with obesity or excess weight who have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol
Click Yes or No below to let us know!
In head-to-head comparisons from trial data: Semaglutide 2.4 mg produces around 15% body weight loss over 68 weeks (STEP 1 trial) Tirzepatide 15 mg produces around 20.9% body weight loss over 72 weeks (SURMOUNT-1 trial) Retatrutide 12 mg produced 24.2% body weight loss over 48 weeks (Phase 2 trial, NEJM 2023) Retatrutide is producing more weight loss in less time
For further queries, don't hesitate to contact us
&srotate=0)
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
